Benefits and risks of switching from protease inhibitors to nevirapine with stable background therapy in patients with low or undetectable viral load: A multicentre study

Andrea De Luca; Francesco Baldini; Antonella Cingolani; Simona Di Giambenedetto; Mauro Zaccarelli; Valerio Tozzi; Adriana Ammassari; Rita Murri; Andrea Antinori

doi:10.1097/00002030-200007280-00022

Benefits and risks of switching from protease inhibitors to nevirapine with stable background therapy in patients with low or undetectable viral load: A multicentre study

Andrea De Luca, Francesco Baldini, Antonella Cingolani, Simona Di Giambenedetto, Mauro Zaccarelli, Valerio Tozzi, Adriana Ammassari, Rita Murri, Andrea Antinori

Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1655-1656
Number of pages	2
Journal	AIDS (London, England)
Volume	14
Issue number	11
DOIs	https://doi.org/10.1097/00002030-200007280-00022
Publication status	Published - 2000

ASJC Scopus subject areas

Immunology and Allergy
Immunology

Access to Document

10.1097/00002030-200007280-00022

Cite this

De Luca, A., Baldini, F., Cingolani, A., Di Giambenedetto, S., Zaccarelli, M., Tozzi, V., Ammassari, A., Murri, R., & Antinori, A. (2000). Benefits and risks of switching from protease inhibitors to nevirapine with stable background therapy in patients with low or undetectable viral load: A multicentre study. AIDS (London, England), 14(11), 1655-1656. https://doi.org/10.1097/00002030-200007280-00022

Benefits and risks of switching from protease inhibitors to nevirapine with stable background therapy in patients with low or undetectable viral load : A multicentre study. / De Luca, Andrea; Baldini, Francesco; Cingolani, Antonella; Di Giambenedetto, Simona; Zaccarelli, Mauro; Tozzi, Valerio; Ammassari, Adriana; Murri, Rita; Antinori, Andrea.

In: AIDS (London, England), Vol. 14, No. 11, 2000, p. 1655-1656.

Research output: Contribution to journal › Article › peer-review

De Luca, A, Baldini, F, Cingolani, A, Di Giambenedetto, S, Zaccarelli, M, Tozzi, V, Ammassari, A, Murri, R & Antinori, A 2000, 'Benefits and risks of switching from protease inhibitors to nevirapine with stable background therapy in patients with low or undetectable viral load: A multicentre study', AIDS (London, England), vol. 14, no. 11, pp. 1655-1656. https://doi.org/10.1097/00002030-200007280-00022

De Luca, Andrea ; Baldini, Francesco ; Cingolani, Antonella ; Di Giambenedetto, Simona ; Zaccarelli, Mauro ; Tozzi, Valerio ; Ammassari, Adriana ; Murri, Rita ; Antinori, Andrea. / Benefits and risks of switching from protease inhibitors to nevirapine with stable background therapy in patients with low or undetectable viral load : A multicentre study. In: AIDS (London, England). 2000 ; Vol. 14, No. 11. pp. 1655-1656.

@article{958be356cba04a1daba5bafe9ba8f217,

title = "Benefits and risks of switching from protease inhibitors to nevirapine with stable background therapy in patients with low or undetectable viral load: A multicentre study",

author = "{De Luca}, Andrea and Francesco Baldini and Antonella Cingolani and {Di Giambenedetto}, Simona and Mauro Zaccarelli and Valerio Tozzi and Adriana Ammassari and Rita Murri and Andrea Antinori",

year = "2000",

doi = "10.1097/00002030-200007280-00022",

language = "English",

volume = "14",

pages = "1655--1656",

journal = "AIDS",

issn = "0269-9370",

publisher = "NLM (Medline)",

number = "11",

}

TY - JOUR

T1 - Benefits and risks of switching from protease inhibitors to nevirapine with stable background therapy in patients with low or undetectable viral load

T2 - A multicentre study

AU - De Luca, Andrea

AU - Baldini, Francesco

AU - Cingolani, Antonella

AU - Di Giambenedetto, Simona

AU - Zaccarelli, Mauro

AU - Tozzi, Valerio

AU - Ammassari, Adriana

AU - Murri, Rita

AU - Antinori, Andrea

PY - 2000

Y1 - 2000

UR - http://www.scopus.com/inward/record.url?scp=0033821022&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033821022&partnerID=8YFLogxK

U2 - 10.1097/00002030-200007280-00022

DO - 10.1097/00002030-200007280-00022

M3 - Article

C2 - 10983653

AN - SCOPUS:0033821022

VL - 14

SP - 1655

EP - 1656

JO - AIDS

JF - AIDS

SN - 0269-9370

IS - 11

ER -

Benefits and risks of switching from protease inhibitors to nevirapine with stable background therapy in patients with low or undetectable viral load: A multicentre study

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this